SCHEMBL6185885

SCHEMBL6185885

COC(=O)C1CC(CC(=O)OC(C)(C)C)CN1C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.40
MMP2 P08253 2/20 0.38
ANPEP P15144 2/20 0.38
NR1H3 Q13133 1/20 0.38
PTPN1 P18031 1/20 0.38
CYP3A4 P08684 3/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
P2RX3 P56373 1/20 0.35
BRD4 O60885 1/20 0.35
TGM2 P21980 1/20 0.34
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTRA1 Q92743 1/20 0.33
PDE4B Q07343 1/20 0.33
PEPD P12955 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31000687 1.00 NR1H2 (0.40) NR1H2MMP2ANPEPNR1H3PTPN1
SCHEMBL29851070 1.00 NR1H2 (0.40) NR1H2MMP2ANPEPNR1H3PTPN1
SCHEMBL17317642 0.89 NR1H2 (0.40) NR1H2MMP2ANPEPNR1H3PTPN1
SCHEMBL9601879 0.89 NR1H2 (0.40) NR1H2MMP2ANPEPNR1H3PTPN1
SCHEMBL6184330 0.89 NR1H2 (0.40) NR1H2MMP2ANPEPNR1H3PTPN1
SCHEMBL19097280 0.89 NR1H2 (0.40) NR1H2MMP2ANPEPNR1H3PTPN1
SCHEMBL15815897 0.86 NR1H2 (0.41) NR1H2MMP2ANPEPNR1H3PTPN1
SCHEMBL18829250 0.86 NR1H2 (0.51) NR1H2MMP2ANPEPNR1H3PTPN1
SCHEMBL2708302 0.86 NR1H2 (0.51) NR1H2MMP2ANPEPNR1H3PTPN1
SCHEMBL2708360 0.86 NR1H2 (0.41) NR1H2MMP2ANPEPNR1H3PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050256166-A1 Nitrogen-containing compounds ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1535906-A1 NITROGEN-CONTAINING COMPOUNDS ONO PHARMACEUTICAL CO., LTD. (JP) 2005-06-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256166-A1 Nitrogen-containing compounds DPP4, DPP3, DPP8 NR1H2 3917/4885MMP2 14/4885ANPEP 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.